KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Change in Accured Expenses (2018 - 2025)

Steris has reported Change in Accured Expenses over the past 8 years, most recently at $25.6 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $25.6 million for Q4 2025, down 16.88% from a year ago — trailing twelve months through Dec 2025 was $16.9 million (up 23.6% YoY), and the annual figure for FY2025 was $38.9 million, down 2.54%.
  • Change in Accured Expenses for Q4 2025 was $25.6 million at Steris, up from -$42.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for STE hit a ceiling of $47.2 million in Q4 2023 and a floor of -$85.9 million in Q3 2022.
  • Median Change in Accured Expenses over the past 5 years was $10.6 million (2021), compared with a mean of $1.4 million.
  • Biggest five-year swings in Change in Accured Expenses: crashed 1344.01% in 2022 and later skyrocketed 3410.02% in 2023.
  • Steris' Change in Accured Expenses stood at $17.3 million in 2021, then soared by 165.7% to $46.0 million in 2022, then rose by 2.63% to $47.2 million in 2023, then plummeted by 34.74% to $30.8 million in 2024, then dropped by 16.88% to $25.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were $25.6 million (Q4 2025), -$42.9 million (Q3 2025), and -$9.2 million (Q2 2025) per Business Quant data.